#LCSM Chat Topic 03-Jun-2021: Making the Most of #ASCO21

Oncology conferences such as those offered by ASCO (American Society for Clinical Oncology), ESMO (European Society for Medical Oncology), and IASLC (International Association for the Study of Lung Cancer) are premier sources for connecting with others in the  lung cancer community, learning about different aspects of lung cancer research and policy, and highlighting key research results.  The entire lung cancer community can help in disseminating results of research that impacts us.   On Thursday, June 3, at 8 pm Eastern Time (5 pm Pacific), #LCSM Chat will discuss ways the community make… Read More

#LCSM Chat Topic 2019-02-07: Is it worth the drive?

Unfortunately, you just got diagnosed with cancer.  You and your family are desperately trying to figure out where to go and which doctor to see.  But how far are you willing to go?  Can you be more confident in your diagnosis, decrease your complications, and improve your chances of survival if you drive a little farther, past your local hospital, to a specialized center that treats a higher volume of cancer patients?  What would it take for you, the patient, to go that extra distance? Seminal surgical studies have described a “volume… Read More

#LCSM Chat Topic 11/1: #LCAM and the Evolution of Lung Cancer Advocacy

November 1 marks the beginning of Lung Cancer Awareness Month (#LCAM). During our next #LCSM Chat on Twitter, we will talk about how lung cancer advocacy has evolved over the past five years since #LCSM Chat began in the summer of 2013, as well as #LCAM 2018 social media resources and planned events. (Note we’re using #LCAM, not #LCAM2018 or #LCAM18–the #LCAM2018 and #LCAM18 hashtags have been taken by the liver cancer community this October). Moderator Janet Freeman-Daily (@JFreemanDaily) will lead our discussion using the following questions: T1: In your view, how… Read More